ardana plc (ARA:London)

Executive Profile*

Background*

Dr. Simon G. Best, OBE FRSE serves as the Chief Executive Officer of Geron Bio-Med. Dr. Best serves as Entrepreneur-in-Residence and is Partner at TVM Capital (Munich, Germany). He serves as Non-executive Partner of PAR Equity. Dr. Best has over 25 years experience across the life science sector in pharmaceuticals, agbiotech, chemicals and industrial enzymes. He served as the Chief Executive Officer at Aquapharm Biodiscovery Limited since March 2010. Through this time, ... Dr. Best has gained significant entrepreneurial and senior management experience of raising finance, deal formation and product commercialisation. Dr. Best co-founded Ardana Plc in 2000 and served as its Chief Executive Officer until 2004. He served as Managing Director and Chief Executive Officer at Zeneca Plant Sciences, where he managed its joint ventures and acquisition programmes. He served as Founding Chief Executive Officer of Roslin Bio-Med, responsible for the commercialisation of the technology that developed Dolly the Sheep, including the merger of the business into the US-listed biotech company Geron Corp. He serves as Chairman of Advisory Board of PAR Equity. Dr. Best serves as Chairman of Ardana Bioscience Ltd. He serves as Chairman of Edinburgh University Technology Fund. He was the Chairman of BioIndustry Association (BIA) from 2006 to 2007. He served as Non-Executive Chairman of Ardana Plc since March 3, 2005. From 2005 to 2010, he built a portfolio of Chair, Board and Advisory roles with Biotech Companies and Investors in Europe, the USA and India. In total, Prof. Best has helped raise over £135m from Public, Private and Corporate Investors in the past 15 years. He served as Chairman of the Board at ICRISAT (Hyderabad, India). Dr. Best served as Executive Chairman of Ardana Plc from May 2004 to March 2005. He served as Non-Executive Chairman of Neuro3d S.A. since September 2005. He served as Vice-Chairman of BIO, USA from 1994 to 1996. He is a Member of the Board and Chair of the Bioethics Committee from 1998 to2005. He served as a Governor of the Food and Agriculture Section of the World Economic Forum (WEF) from 1994-98. Dr. Best serves as Director of Aquapharm Biodiscovery Limited and Ohmedics. He is a Member of Advisory Panel of Par Equity LLP. He has been a Director of DIREVO Biotech AG since July 2007. He serves as Director of PathXL Ltd. He serves as a Non-Executive Director of Avesthagen Pvt. Ltd. He has been a Non-Executive Director of Ardana Plc since May 2004. He serves as a Non Executive Director at Polytherics. He served as a Director of Biotechnology Industry Organization. Dr. Best served as Director of Targeted Growth, Inc. He served as a Director of Entelos Inc., since December 2005. Dr. Best served as a Director of Avestha Gengraine Technologies Pvt Ltd. He serves as Director of Advisory Board of PAR Equity. He served as a Director of Neuro3d S.A. March 2008, he was appointed to the Executive Board and as Vice-Chairman of the UK India Business Council (UKIBC). He served as a Member of supervisory board of DIREVO Biotech AG. He is the Chairman of the BioQuarter Commercialisation Board. He is a Non-Executive Director of International Potato Centre and is a Member of the UK Bioscience Leadership Council (BLC). In August 2008, he is a Visiting Professor of Medicine by the University of Edinburgh. In 1999, he was nominated by the World Economic Forum as a “Global Leader of Tomorrow“ and in 2000 as a “Technology Pioneer of the Year.“ In September 1999, he was nominated as “Science and Technology Venturer of the Year“ by the Financial Times. In 2007, he was elected a Fellow of the Royal Society of Edinburgh (FRSE) and awarded the LBS Alumni Achievement Prize. In 2008, he was awarded an OBE. In June 2008, he was awarded the Order of the British Empire (OBE) in the Queen's Birthday Honors List. Dr. Best received Bachelor of Music and Honorary Doctorate from the University of York in 1977 and his MBA from London Business School (LBS) in 1985 where he was the recipient of the Alan Patricof and Associates (APAX) Venture Capital prize. Dr. Best received his Bachelor of Music from the University of York in 1977 and his MBA from London Business School (LBS) in 1985 where he was the recipient of the Alan Patricof and Associates (APAX) Venture Capital prize. In 2004, he was awarded an Honorary Ph.D from the University of York for his contributions to Music, Biotechnology and Medicine.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ARA:LN	0.00 GBp	0.00

COMPETITOR COMPENSATION